Katrin Leadley

Dr. Leadley is a seasoned clinical executive bringing medical and scientific expertise to Endotronix. Before joining Endotronix, Dr. Leadley was the Chief Medical Officer at HeartWare (acquired by Medtronic in 2016) where she was responsible for all medical, clinical, and regulatory affairs, including the design and execution of HeartWare’s clinical trial program. Prior to HeartWare, Dr. Leadley served as the Chief Medical Officer at JenaValve Technology. She has also held a variety of leadership positions in Clinical Services at Boston Scientific Corporation with increasing responsibility. Prior to Boston Scientific, Dr. Leadley held managerial positions at several other life sciences companies, including Advanced Stent Technologies, Pulmonx, and Quintiles/The Lewin Group in San Francisco. She has authored numerous scientific and medical publications and presented at industry conferences and events around the world.

Dr. Leadley earned her medical degree at Ludwig-Maximillian University Medical School in Munich. She was also awarded a National Institute of Health Postdoctoral Fellowship by the School of Public Health at the University of California at Berkeley.